{{Rsnum
|rsid=315943
|Chromosome=2
|position=113136761
|Orientation=plus
|GMAF=0.2943
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 16.1 | 54.5 | 29.5
| HCB | 0.7 | 19.7 | 79.6
| JPT | 0.0 | 14.2 | 85.8
| YRI | 16.3 | 42.9 | 40.8
| ASW | 14.0 | 52.6 | 33.3
| CHB | 0.7 | 19.7 | 79.6
| CHD | 0.0 | 11.9 | 88.1
| GIH | 21.8 | 42.6 | 35.6
| LWK | 7.3 | 37.3 | 55.5
| MEX | 8.6 | 43.1 | 48.3
| MKK | 13.5 | 48.7 | 37.8
| TSI | 15.7 | 57.8 | 26.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23602982
|Title=IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}